[{"id":"72987062-8538-43db-9b8d-792c8619cbf1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05190471","created_at":"2022-01-13T13:56:12.332Z","updated_at":"2024-07-02T16:35:39.559Z","phase":"Phase 1","brief_title":"A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)","source_id_and_acronym":"NCT05190471","lead_sponsor":"Bio-Path Holdings, Inc.","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e decitabine • BP1002"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 08/16/2022","start_date":" 08/16/2022","primary_txt":" Primary completion: 03/01/2024","primary_completion_date":" 03/01/2024","study_txt":" Completion: 09/01/2024","study_completion_date":" 09/01/2024","last_update_posted":"2023-08-21"}]